IMCD’s Pharma Technical Centre successfully concluded its inaugural Controlled Release School on 12th & 13th August 2026, bringing together formulation professionals for two days of focused learning, practical demonstrations, and valuable industry insights. The program covered controlled-release matrix formulations, osmotic drug delivery, and pellet coating technologies, blending scientific concepts with hands-on application.
A key highlight was the industry-led sessions by Dr. Amit Gupta, Assistant Vice President - Macleods Pharmaceuticals, on 505(b)(2) opportunities, and Mr. Sanjay Motipwar, VP & Global Head MSAT Glenmark Pharmaceuticals, who shared real-world perspectives on troubleshooting of extended-release formulations, from identifying root causes to optimizing coating processes.
With a strong balance of science, practical learning, and industry experience, the two-day program highlighted how deeper technical understanding and the right formulation strategies can transform challenges into robust, patient-centric solutions. Two days. One shared purpose. The Controlled Release School further reflects IMCD India’s ongoing efforts to foster innovation, strengthen technical capabilities, and promote meaningful collaboration across the pharmaceutical industry.